BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12453589)

  • 1. [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice.
    Zheng QH; Stone KL; Mock BH; Miller KD; Fei X; Liu X; Wang JQ; Glick-Wilson BE; Sledge GW; Hutchins GD
    Nucl Med Biol; 2002 Nov; 29(8):803-7. PubMed ID: 12453589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.
    Zheng QH; Fei X; Liu X; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Miller KD; Sledge GW; Hutchins GD
    Nucl Med Biol; 2004 Jan; 31(1):77-85. PubMed ID: 14741572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
    Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD
    Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.
    Zheng QH; Gardner TA; Raikwar S; Kao C; Stone KL; Martinez TD; Mock BH; Fei X; Wang JQ; Hutchins GD
    Bioorg Med Chem; 2004 Jun; 12(11):2887-93. PubMed ID: 15142549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues.
    Fei X; Zheng QH; Wang JQ; Stone KL; Martinez TD; Miller KD; Sledge GW; Hutchins GD
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1247-51. PubMed ID: 14980675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and preclinical evaluation of the choline transport tracer deshydroxy-[18F]fluorocholine ([18F]dOC).
    Henriksen G; Herz M; Hauser A; Schwaiger M; Wester HJ
    Nucl Med Biol; 2004 Oct; 31(7):851-8. PubMed ID: 15464386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of [(11)C]Choline ([(11)C]CHO) and [(18)F]Bombesin (BAY 86-4367) as Imaging Probes for Prostate Cancer in a PC-3 Prostate Cancer Xenograft Model.
    Schwarzenböck SM; Schmeja P; Kurth J; Souvatzoglou M; Nawroth R; Treiber U; Kundt G; Berndt S; Graham K; Senekowitsch-Schmidtke R; Schwaiger M; Ziegler SI; Dinkelborg L; Wester HJ; Krause BJ
    Mol Imaging Biol; 2016 Jun; 18(3):393-401. PubMed ID: 26483088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated synthesis of [11C]choline, a positron-emitting tracer for tumor imaging.
    Hara T; Yuasa M
    Appl Radiat Isot; 1999 Mar; 50(3):531-3. PubMed ID: 10070713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET imaging of brain tumor with [methyl-11C]choline.
    Hara T; Kosaka N; Shinoura N; Kondo T
    J Nucl Med; 1997 Jun; 38(6):842-7. PubMed ID: 9189127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer.
    Amano S; Inoue T; Tomiyoshi K; Ando T; Endo K
    J Nucl Med; 1998 Aug; 39(8):1424-7. PubMed ID: 9708521
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Han N; Jiang Y; Gai Y; Liu Q; Yuan L; Wang Y; Li M; Zhang Y; Lan X
    Contrast Media Mol Imaging; 2019; 2019():1760184. PubMed ID: 31787861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
    Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM
    Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model].
    Schwarzenböck S; Sachs D; Souvatzoglou M; Schuster T; Nawroth R; Weirich G; Treiber U; Wester HJ; Ziegler S; Schwaiger M; Senekowitsch-Schmidtke R; Krause BJ
    Nuklearmedizin; 2013; 52(4):141-7. PubMed ID: 23396481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
    Kukuk D; Reischl G; Raguin O; Wiehr S; Judenhofer MS; Calaminus C; Honndorf VS; Quintanilla-Martinez L; Schönberger T; Duchamp O; Machulla HJ; Pichler BJ
    J Nucl Med; 2011 Oct; 52(10):1654-63. PubMed ID: 21859811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
    McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
    J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.
    Michelhaugh SK; Muzik O; Guastella AR; Klinger NV; Polin LA; Cai H; Xin Y; Mangner TJ; Zhang S; Juhász C; Mittal S
    J Nucl Med; 2017 Feb; 58(2):208-213. PubMed ID: 27765857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.